Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
Vazquez JA, González Patzán LD, Stricklin D, Duttaroy DD, Kreidly Z, Lipka J, Sable C. Vazquez JA, et al. Among authors: sable c. Curr Med Res Opin. 2012 Dec;28(12):1921-31. doi: 10.1185/03007995.2012.748653. Epub 2012 Nov 21. Curr Med Res Opin. 2012. PMID: 23145859 Clinical Trial.
Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.
Lucasti C, Popescu I, Ramesh MK, Lipka J, Sable C. Lucasti C, et al. Among authors: sable c. J Antimicrob Chemother. 2013 May;68(5):1183-92. doi: 10.1093/jac/dks523. Epub 2013 Feb 7. J Antimicrob Chemother. 2013. PMID: 23391714 Clinical Trial.
Caspofungin for the treatment of less common forms of invasive candidiasis.
Cornely OA, Lasso M, Betts R, Klimko N, Vazquez J, Dobb G, Velez J, Williams-Diaz A, Lipka J, Taylor A, Sable C, Kartsonis N. Cornely OA, et al. Among authors: sable c. J Antimicrob Chemother. 2007 Aug;60(2):363-9. doi: 10.1093/jac/dkm169. Epub 2007 May 26. J Antimicrob Chemother. 2007. PMID: 17526917
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.
Maertens J, Glasmacher A, Herbrecht R, Thiebaut A, Cordonnier C, Segal BH, Killar J, Taylor A, Kartsonis N, Patterson TF, Aoun M, Caillot D, Sable C; Caspofungin Combination Therapy Study Group. Maertens J, et al. Among authors: sable c. Cancer. 2006 Dec 15;107(12):2888-97. doi: 10.1002/cncr.22348. Cancer. 2006. PMID: 17103444 Free article. Clinical Trial.
Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.
Colombo AL, Perfect J, DiNubile M, Bartizal K, Motyl M, Hicks P, Lupinacci R, Sable C, Kartsonis N. Colombo AL, et al. Among authors: sable c. Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):470-4. doi: 10.1007/s10096-003-0973-8. Epub 2003 Jul 23. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12884068 Clinical Trial.
Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J; Caspofungin Invasive Candidiasis Study Group. Mora-Duarte J, et al. Among authors: sable c. N Engl J Med. 2002 Dec 19;347(25):2020-9. doi: 10.1056/NEJMoa021585. N Engl J Med. 2002. PMID: 12490683 Free article. Clinical Trial.
271 results